Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) is licensed in the UK for adults with a BMI of 30 or above, or a BMI of 27 or above if at least one weight-related health condition is present — so a lower BMI doesn't automatically rule you out. A prescriber reviews your full clinical picture before any decision is made, because Mounjaro is a prescription-only medicine that cannot legally be supplied without clinical assessment. If your BMI falls in the 27–29.9 range and you have a qualifying condition such as high blood pressure, type 2 diabetes, high cholesterol, obstructive sleep apnoea, or prediabetes, there may be a legitimate, clinically appropriate route to treatment. Understanding exactly where the threshold sits, and how a regulated online pharmacy like nume handles this, is the quickest way to find out where you stand.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Not necessarily. The licensed eligibility criteria for Mounjaro in the UK set two separate thresholds. The first is a BMI of 30 or above, with no additional conditions required. The second is a BMI between 27 and 29.9, provided you have at least one weight-related comorbidity. The NHS patient information for tirzepatide confirms this structure, reflecting the Summary of Product Characteristics approved by the MHRA.
Weight-related conditions that can qualify at the lower threshold include type 2 diabetes, prediabetes, hypertension, dyslipidaemia (raised cholesterol or triglycerides), obstructive sleep apnoea, and osteoarthritis, among others. If one of those applies to you and your BMI sits at 27 or above, a prescriber can legitimately consider Mounjaro. Below 27, it falls outside the licensed indication altogether, and a responsible prescriber will not issue a prescription.
One useful habit before starting any consultation: pull up the NHS BMI calculator, enter your current height and weight, and note the figure. It takes under a minute and means you arrive at the consultation with an accurate number rather than an estimate. BMI is only one part of what a prescriber considers, but knowing yours precisely helps.
For a fuller breakdown of what the threshold looks like in practice, including what BMI the NHS uses for Mounjaro eligibility, the Mounjaro overview covers the clinical background in more detail.
A qualifying condition isn't self-declared. The prescriber needs to be satisfied, through your consultation responses and any supporting information, that the condition is real and clinically relevant. At nume, that process includes a structured health questionnaire, live weight verification on video, photo-ID checks, and access to Summary Care Record data where appropriate. If you are transferring from another provider or requesting a dose increase, evidence of your current treatment and progress is also reviewed.
This matters because the BMI 27–29.9 bracket with a comorbidity is a narrower clinical window than simply being above 30. Prescribers weigh up not just whether you technically meet the numbers but whether the overall clinical picture supports treatment. That is not a barrier for eligible patients, it is the assessment that makes the prescription safe and lawful.
Under-18s are not eligible regardless of BMI or health conditions. Mounjaro is not recommended during pregnancy, while breastfeeding, or for those actively trying to conceive; a prescriber will discuss this if relevant. Getting Mounjaro with a BMI under 30 covers the specific clinical questions in that range in more depth.
The only lawful route to Mounjaro in the UK is a valid prescription following clinical assessment. There are two main paths: through the NHS, or through a regulated private service.
On the NHS, access is phased and tied to strict eligibility criteria managed by NICE guidance. As of summer 2026, the NHS route for tirzepatide requires a BMI of 40 or above alongside multiple qualifying conditions, with thresholds easing in later cohorts. If your BMI is lower, the NHS route is very unlikely to apply to you currently, the NHS BMI requirements for Mounjaro explains the phased rollout in full.
The private route goes through a registered pharmacy following a clinical consultation. If you want a clear picture of how to get Mounjaro through a regulated private service, at nume the process is: complete a free online consultation, have it reviewed the same day by a GPhC-registered Independent Prescriber, pass identity and weight verification, then receive your treatment by free next-working-day DPD delivery if approved. No subscription. Every repeat order is clinically re-reviewed before dispatch.
Before using any online pharmacy, verify it on the official register at the GPhC pharmacy register. nume's GPhC premises registration number is 9012878. Any pharmacy unwilling or unable to point you to its GPhC registration is a red flag worth taking seriously.
The MHRA has issued repeated public warnings about counterfeit weight-loss injection pens sold through social media and unverified websites. In October 2025, enforcement teams raided the UK's first illicit manufacturing site producing fake tirzepatide pens, and approximately 20 million doses of illegally traded weight-loss medicines (around £45 million in street value) were seized across 2025. Fake pens have been found to contain insulin in place of the labelled medicine, with potentially life-threatening consequences.
The red flags are consistent: sellers offering prescription medicines without asking for a consultation, prices far below the private market range, and promotional codes or discount vouchers attached to a prescription medicine. No legitimate pharmacy runs discount codes on a POM. The MHRA's guidance is clear: buy only from a pharmacy you can verify, and report suspect sellers via Yellow Card.
A common question at this stage is whether you can order Mounjaro from different pharmacies if you want to compare services or switch providers. If you've already found a pharmacy and want to check its status, the GPhC register search takes seconds. For questions about the consultation process at nume specifically, the FAQs page covers the most common ones, and the contact page connects you with the support team directly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.